0
0
44 words
0
Comments
A clinician offers his perspective on what he sees as a clinician and trial investigator in terms of what is in the pipeline and both the encouraging data and uncertainty in therapy development overall.
You are the first to view
https://www.contagionlive.com/view/antibiotic-development-glass-half-full-or-half-empty-
Create an account or login to join the discussion